Literature DB >> 29174627

Role of NMDA receptor GluN2D subunit in the antidepressant effects of enantiomers of ketamine.

Soichiro Ide1, Yuiko Ikekubo1, Masayoshi Mishina2, Kenji Hashimoto3, Kazutaka Ikeda4.   

Abstract

We investigated the rapid and sustained antidepressant effects of enantiomers of ketamine in N-methyl-d-aspartate (NMDA) receptor GluN2D subunit knockout (GluN2D-KO) mice. Intraperitoneal administration of ketamine or its enantiomers 10 min before the tail-suspension test exerted significant antidepressant effects on restraint stress-induced depression in both wildtype and GluN2D-KO mice. The antidepressant effects of (RS)-ketamine and (S)-ketamine were sustained 96 h after the injection in both wildtype and GluN2D-KO mice, but such sustained antidepressant effects of (R)-ketamine were only observed in wildtype mice. These data suggest that the GluN2D subunit is critical for the sustained antidepressant effects of (R)-ketamine.
Copyright © 2017 The Authors. Production and hosting by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Depression; GluN2D; Ketamine

Mesh:

Substances:

Year:  2017        PMID: 29174627     DOI: 10.1016/j.jphs.2017.11.001

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  8 in total

1.  GluN2D NMDA Receptors Gate Fear Extinction Learning and Interneuron Plasticity.

Authors:  Christophe J Dubois; Siqiong June Liu
Journal:  Front Synaptic Neurosci       Date:  2021-05-24

Review 2.  Brain NMDA Receptors in Schizophrenia and Depression.

Authors:  Albert Adell
Journal:  Biomolecules       Date:  2020-06-23

3.  Differential effect of NMDA receptor GluN2C and GluN2D subunit ablation on behavior and channel blocker-induced schizophrenia phenotypes.

Authors:  Gajanan P Shelkar; Ratnamala Pavuluri; Pauravi J Gandhi; Aparna Ravikrishnan; Dinesh Y Gawande; Jinxu Liu; Dustin J Stairs; Rajesh R Ugale; Shashank M Dravid
Journal:  Sci Rep       Date:  2019-05-20       Impact factor: 4.379

4.  Cognitive Impairment That Is Induced by (R)-Ketamine Is Abolished in NMDA GluN2D Receptor Subunit Knockout Mice.

Authors:  Soichiro Ide; Yuiko Ikekubo; Masayoshi Mishina; Kenji Hashimoto; Kazutaka Ikeda
Journal:  Int J Neuropsychopharmacol       Date:  2019-07-01       Impact factor: 5.176

5.  Multiple roles of GluN2D-containing NMDA receptors in short-term potentiation and long-term potentiation in mouse hippocampal slices.

Authors:  Alen V Eapen; Diego Fernández-Fernández; John Georgiou; Zuner A Bortolotto; Stafford Lightman; David E Jane; Arturas Volianskis; Graham L Collingridge
Journal:  Neuropharmacology       Date:  2021-10-09       Impact factor: 5.250

6.  MicroRNA-8126-Mediated Antioxidant Stress Attenuates Isoflurane-Induced Hippocampal Neurotoxicity in Developing Rats.

Authors:  Wen Pan; WenFeng Xiao; LingShuai Xue; Chao You
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-17       Impact factor: 2.650

7.  Pharmacological Comparative Characterization of REL-1017 (Esmethadone-HCl) and Other NMDAR Channel Blockers in Human Heterodimeric N-Methyl-D-Aspartate Receptors.

Authors:  Ezio Bettini; Stephen M Stahl; Sara De Martin; Andrea Mattarei; Jacopo Sgrignani; Corrado Carignani; Selena Nola; Patrizia Locatelli; Marco Pappagallo; Charles E Inturrisi; Francesco Bifari; Andrea Cavalli; Andrea Alimonti; Luca Pani; Maurizio Fava; Sergio Traversa; Franco Folli; Paolo L Manfredi
Journal:  Pharmaceuticals (Basel)       Date:  2022-08-13

8.  Abolished ketamine effects on the spontaneous excitatory postsynaptic current of medial prefrontal cortex neurons in GluN2D knockout mice.

Authors:  Dae Hee Han; Ilgang Hong; Ja Eun Choi; Pojeong Park; Jun-Yeong Baek; HyoJin Park; Soichiro Ide; Masayoshi Mishina; Kazutaka Ikeda; Bong-Kiun Kaang
Journal:  Mol Brain       Date:  2021-12-07       Impact factor: 4.041

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.